Nomogram predicts death, recurrence with thyroid cancer

Nomogram predicts death, recurrence with thyroid cancer

(HealthDay)—A new nomogram has excellent discriminatory ability and accuracy in predicting 10-year disease-specific death and recurrence for papillary thyroid carcinoma (PTC), according to a study published online Sept. 2 in Head & Neck.

Brian H.H. Lang, from the University of Hong Kong, and colleagues developed and validated a nomogram to provide individualized prognosis (death and recurrence) for PTC.

The researchers found that the nomogram had excellent discrimination in predicting 10-year disease-specific death and recurrence (0.984 and 0.743, respectively). One-hundred percent of the patients surviving at 10 years had a score <30, and those who died within 10 years had a score ≥30. Almost all the patients (91.04 percent) were disease-free within 10 years with a score of <17.

"Using a competing-risk model, a nomogram was created with excellent discriminatory ability and accuracy in predicting 10-year disease-specific and recurrence for PTC," the authors write. "Our results implied its potential for wider use in other populations."


Explore further

No specific findings to ID recurrence in head and neck CA

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2015 HealthDay. All rights reserved.

Citation: Nomogram predicts death, recurrence with thyroid cancer (2015, October 1) retrieved 13 November 2019 from https://medicalxpress.com/news/2015-10-nomogram-death-recurrence-thyroid-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
5 shares

Feedback to editors

User comments